| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
|
N Engl J Med
|
2004
|
13.34
|
|
2
|
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
|
J Gastrointest Surg
|
2001
|
8.34
|
|
3
|
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
|
Ann Surg
|
1999
|
6.93
|
|
4
|
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.
|
J Clin Oncol
|
2001
|
4.89
|
|
5
|
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.
|
Ann Surg Oncol
|
2006
|
4.50
|
|
6
|
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study.
|
Br J Surg
|
1995
|
3.42
|
|
7
|
Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.
|
Cancer
|
1987
|
3.24
|
|
8
|
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
|
Ann Surg
|
2001
|
2.94
|
|
9
|
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
|
J Clin Oncol
|
1997
|
2.75
|
|
10
|
The use of active breathing control (ABC) to reduce margin for breathing motion.
|
Int J Radiat Oncol Biol Phys
|
1999
|
2.75
|
|
11
|
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
|
Ann Surg Oncol
|
2001
|
2.24
|
|
12
|
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
2.12
|
|
13
|
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
|
Ann Surg Oncol
|
2005
|
1.88
|
|
14
|
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
|
J Clin Oncol
|
1998
|
1.61
|
|
15
|
The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain.
|
Cancer
|
1987
|
1.57
|
|
16
|
Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.
|
J Clin Oncol
|
2002
|
1.54
|
|
17
|
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.
|
J Gastrointest Surg
|
2001
|
1.50
|
|
18
|
Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.41
|
|
19
|
Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer.
|
Radiother Oncol
|
2003
|
1.38
|
|
20
|
Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique.
|
Radiother Oncol
|
2005
|
1.37
|
|
21
|
MRI-based measurements of respiratory motion variability and assessment of imaging strategies for radiotherapy planning.
|
Phys Med Biol
|
2006
|
1.25
|
|
22
|
Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.18
|
|
23
|
Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.
|
Am J Surg
|
2004
|
1.10
|
|
24
|
Clinical results of proton beam therapy for cancer of the esophagus.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.05
|
|
25
|
Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO).
|
BMC Cancer
|
2007
|
1.03
|
|
26
|
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.
|
Int J Gastrointest Cancer
|
2003
|
1.01
|
|
27
|
Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.
|
JOP
|
2006
|
0.95
|
|
28
|
Comparative treatment planning between proton and X-ray therapy in pancreatic cancer.
|
Med Dosim
|
2001
|
0.86
|
|
29
|
A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: implications for radiation dose escalation in carcinoma of the pancreas.
|
Radiat Oncol
|
2006
|
0.80
|
|
30
|
Neoadjuvant therapy in pancreatic cancer: an emerging strategy.
|
Gastroenterol Res Pract
|
2014
|
0.78
|